In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001398:Aztreonam; D001419:Bacteria / Q000201:enzymology; D001441:Bacteroides fragilis / Q000187:drug effects; D002692:Chlamydia trachomatis / Q000187:drug effects; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects*; D007709:Klebsiella / Q000187:drug effects; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D001618:beta-Lactamases / Q000378:metabolism; D047090:beta-Lactams / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D001618:beta-Lactamases; D001398:Aztreonam